Advanced Search

per page
  Report Title Date Provider Type Pgs Price

Enanta Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Jun 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Enanta Pharmaceuticals Inc (ENTA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 Jun 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for ENTA

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

26 Jun 2016 ValuEngine, Inc. 11 $25.00


", the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

25 Jun 2016 Pechala's Reports 2 $25.00


24 Jun 2016 Ford Investor Services, Inc. 1 $12.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ENANTA PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

24 Jun 2016 Jefferson Research 11 $20.00

Validea Guru Analysis Report for ENTA. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

17 Jun 2016 Validea 0 $12.00

Enanta Pharmaceuticals, Inc. (ENTA) - Financial Analysis Review

Enanta Pharmaceuticals, Inc. (ENTA) - Financial Analysis Review Summary Enanta Pharmaceuticals, Inc. (Enanta) is a biotechnol...

16 Jun 2016 GlobalData 32 $300.00

ENTA.OQ - Event Transcript of Enanta Pharmaceuticals Inc conference call, Jun. 08, 2016 / 3:30PM ET

Edited Event Transcript of ENTA.OQ conference call, Jun. 08, 2016 / 3:30PM ET New York, Jun 23, 2016 (Thomson StreetEve...

08 Jun 2016 Thomson Reuters StreetEvents 6 $75.00

Wright Investors Service Comprehensive Report for Enanta Pharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

07 Jun 2016 Wright Reports 59 $75.00